- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – The Evolving Psychopharmacology Of Major Depressive Disorder
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – The Evolving Psychopharmacology Of Major Depressive Disorder
In this presentation, the objectives are to:
- Provide a brief overview of depression prevalence and current standard treatments
- Review the monoamine hypothesis of depression
- Discuss alternative hypotheses of depression
- Highlight potential new therapeutic intervention targets
Featuring
Philip G. Janicak, MD
Adjunct Professor and Consultant to the Therapeutic Neuromodulation Program in the Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine and a Distinguished Life Fellow in the American Psychiatric Association
MoreDr. Janicak is an Adjunct Professor and Consultant to the Therapeutic Neuromodulation Program in the Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine and a Distinguished Life Fellow in the American Psychiatric Association. He completed his medical training and psychiatric residency at Loyola University of Chicago in 1976. In 1978, he became a research psychiatrist at the Illinois State Psychiatric Institute. He was a Professor of Psychiatry and Pharmacology, the Medical Director of the Psychiatric Clinical Research Center, and the Associate Program Director for the NIH General Clinical Research Center at the University of Illinois Medical Center from 1994-2004. He then became a Professor of Psychiatry at Rush University and was the Director of the Rush Psychiatric Clinical Research and Transcranial Magnetic Stimulation Centers from 2004-2014. He developed and directed the TMS Center at Linden Oaks Medical Group from 2014-2017. Dr. Janicak’s primary research interests are in the assessment and treatment of mood and psychotic disorders. In this context, he has conducted over 60 clinical trials. He has been a NIH grant awardee as both a principal and co-investigator. He has authored, co-authored or edited over 500 publications in the psychiatric literature and is first author of the Principles and Practice of Psychopharmacotherapy. Dr. Janicak was the editor of the Psychopharm Review from 2004-2014 and presently serves on the Editorial Board of Current Psychiatry. He has also been a reviewer for several journals, including: The American Journal of Psychiatry, Biological Psychiatry, JAMA Psychiatry, Journal of the American Medical Association, Journal of ECT, Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology, Psychiatric Annals, Psychiatry Research and Schizophrenia Research. Dr. Janicak was first listed in the Best Doctors of America since 1996 and Who’s Who in America in 2001. Dr. Janicak was named Psychiatrist of the Year by NAMI Illinois for 2003. In 2009, he received the John M. Davis Researcher of the Year Award from NAMI of Greater Chicago. In 2017, he was a recipient of the Who’s Who Albert Nelson Marquis Lifetime Achievement Award. In 2018, he was the recipient of the Illinois Psychiatric Society Educator of the Year Award. He has participated as a principal lecturer in over 500 courses, seminars, symposia and related professional presentations.Rachel Self, PhD, MS (OPDC)
Medical Science Director, Neuroscience Field Medical Affairs
MoreRachel Self, PhD, MS is a Medical Science Director for Otsuka’s Neuroscience Field Medical Affairs, neuroscientist, & wellness advocate.Registration
Related Resources
-
Monoamine Neurotransmitter Dysregulation in Major Depressive Disorder
On-Demand Webinar December 18, 2024Join us for a PsychU webinar with Drs. W. Clay Jackson and Christian Aurup as they discuss the potential relationship between the monoamine neurotransmitter systems in Major Depressive Disorder (MDD).
-
Addressing Caregiver Burden & Identifying Agitation in Alzheimer’s Dementia
On-Demand Webinar November 26, 2024Come and join us for this webinar, as our speaker and moderator highlight the impact of caregiver burden, discuss challenges in recognizing agitation in Alzheimer’s dementia, and share tools that…
-
Treatment Pathways Across Cultures
On-Demand Webinar November 25, 2024During this webinar, Sr. MSL Dr. Michael Aldape will be talking with Dr. Crystal Clark and Dr. Mauricio Tohen as they guide us on a lively discussion addressing the impact…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: